Premium
Infanrix hexa: a hexavalent vaccine for infant immunisation
Author(s) -
Chaplin Steve
Publication year - 2018
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1667
Subject(s) - medicine , diphtheria , tetanus , poliomyelitis , adverse effect , pediatrics , hib vaccine , pertussis vaccine , poliomyelitis vaccine , immunization , virology , vaccination , immunology , conjugate vaccine , antigen
The hexavalent vaccine Infanrix hexa, which protects against hepatitis B in addition to diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b, was introduced to the UK routine infant immunisation schedule in Autumn 2017. This article summarises its efficacy and adverse effects, with an overview of the new immunisation schedule.